Jennifer Clayton
Family · Winter Park, FLNPI 1720763402
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 9.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $870, 4.1 times the $213 reported in 2023.
Across 69 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$149
- Geron Corporation$135
- Johnson & Johnson$117
- AstraZeneca$101
- Novartis$100
- Merck$100
- plus $905 from 21 others
What the payments were for
- Food & beverage$1,607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 6 | $149 |
| Geron Corporation | 1 | $135 |
| Johnson & Johnson | 6 | $117 |
| AstraZeneca(2 entities) | 4 | $101 |
| Novartis | 5 | $100 |
| Merck | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Lilly USA, LLC | 3 | $87 |
| Astellas Pharma US Inc | 4 | $71 |
| Eisai Inc. | 3 | $65 |
| AbbVie | 2 | $59 |
| Bayer | 3 | $59 |
| Gilead | 3 | $53 |
| Incyte Corporation | 3 | $52 |
| Tersera Therapeutics LLC | 2 | $52 |
| Sobi, Inc | 2 | $43 |
| GSK | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Genmab U.S., Inc. | 1 | $25 |
| Blue Earth Diagnostics | 1 | $23 |
| Acrotech Biopharma Inc. | 1 | $22 |
| Array Biopharma Inc | 1 | $21 |
| EMD Serono, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYTELO$135
How this compares
$1,607 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $17,514 |
| Duloxetine Hcl | 11 | $775 |
| Pantoprazole Sodium | 11 | $194 |
| Warfarin Sodium | 14 | $96 |
Paid to pharmacies, not to this prescriber.
Other family in Winter Park
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.